Sentences with phrase «cash less all liabilities»

Based on its December 1, 2008 closing price of $ 0.65, the company has a market capitalization of $ 19.4 M and net cash (i.e. cash less all liabilities) of $ 36.5 M, which means that AVGN is trading at 53 % of its net cash.

Not exact matches

Figures here include all assets (property, cash, equities, business interests) less any liabilities.

Resources Holdings Fund Overview (PDF) Summary Prospectus (PDF): Class P2 * Cash and equivalents includes short - term securities, accrued income, Treasury futures and other assets less liabilities.

* Cash and equivalents includes short - term securities, accrued income, Treasury futures and other assets less liabilities.

So if the Current Asset: Current Liability ratio is less than 1, chances are, the company isn't doing very well — they can't pay back all the money they owe with the cash they'll have on hand and will have to start selling long - term assets, or look at refinancing the company, in order to pay their short - term bills.

Two things must be true — a firm must not be able to raise cash to make a debt payment, and the assets of the firm are worth less than the liabilities.

He looked for profitable firms trading at much less than their current assets (cash and assets that can be turned into cash over the next year) minus all liabilities.

We've been following AVGN (see earlier posts here and here) because it's a net cash stock (i.e. it's trading at less than the value of its cash after deducting all liabilities) and it has a specialist biotechnology activist fund Biotechnology Value Fund (BVF) pushing it to liquidate and return its cash to shareholders.

We've been following AVGN (see earlier posts here, here, here, here, here and here) because it's a net cash stock (i.e. it's trading at less than the value of its cash after deducting all liabilities) and specialist biotechnology activist fund BVF has been pushing it to liquidate and return its cash to shareholders.

We've been following AVGN (see earlier posts here, here and here) because it's a net cash stock (i.e. it's trading at less than the value of its cash after deducting all liabilities) and it has a specialist biotechnology activist fund Biotechnology Value Fund (BVF) pushing it to liquidate and return its cash to shareholders.

We posted about Avigen, Inc. (NASDAQ: AVGN) on December 1, 2008, noting that it was a rare opportunity because it was a net cash stock (i.e. it was trading at less than the value of its cash after deducting all liabilities).

Short term is a concept that refers to holding an asset for a year or less, and accountants use the term «current» to refer to an asset expected to be converted into cash in the next year or a liability coming due in the next year.

And, if the liabilities are called into question, so are those who funded the liabilities, because they are less certain of receiving the cash flows that they expected.

I have a feeling that those net nets would do better than the Neg Ent firms because net nets trading for less than cash are cheaper (the formula takes into account total liabilities, not just debt).

It is derived by dividing the total value of all the cash and securities in a fund's portfolio, less any liabilities, by the number of shares outstanding.

The Net Current Asset Value (NCAV) calculates the value of a firm's cash, inventory, and receivables less all liabilities and preferred stock which is treated as debt.

We opened our position because AVGN was a net cash stock (i.e. it's trading at less than the value of its cash after deducting all liabilities), albeit a cash burning net cash stock, and BVF was pushing it to liquidate and return its cash to shareholders.

Yet, had you focused exclusively on net nets (Graham's famous approach whereby one only buys stock in companies where the sum of current assets less all liabilities exceeds the market value), you would have cashed in 29.4 % annually in the same period.

We've been following AVGN (see archived posts here) because it's a net cash stock (i.e. it's trading at less than the value of its cash after deducting all liabilities) and specialist biotechnology investor Biotechnology Value Fund (BVF) has been pushing it to liquidate and return its cash to shareholders.

The net current assets investment selection criterion calls for the purchase of stocks which are priced at 66 % or less of a company's underlying current assets (cash, receivables and inventory) net of all liabilities and claims senior to a company's common stock (current liabilities, long - term debt, preferred stock, unfunded pension liabilities).

Net working capital consists of current assets (cash, marketable securities, receivables, and inventories) less current liabilities (accounts, notes, and taxes payable within one year.)

Berkshire was a classic «net net» — a stock trading for less than the value of its cash, receivables, and inventory less all liabilities.

We've been following AVGN (see archived posts here) because it's a net cash stock (i.e. it's trading at less than the value of its cash after deducting all liabilities) and specialist biotechnology investor BVF has been pushing it to liquidate and return its cash to shareholders.

We've been following AVGN (see archived posts here) because it's a net cash stock (i.e. it's trading at less than the value of its cash after deducting all liabilities) and specialist biotechnology activist fund BVF has been pushing it to liquidate and return its cash to shareholders.

Right now, VXGN has a lot of cash compared to its liabilities and is trading for less than that.

The number of shares issued at closing will be subject to adjustment if VaxGen's net cash, as of a date shortly before the closing, as agreed by both parties, less certain expenses and liabilities, is greater or less than approximately $ 33.2 million.

We've been following AVGN (see archived posts here) for exactly the reason that Pollack identifies: it's a net cash stock (i.e. it's trading at less than the value of its cash after deducting all liabilities) and specialist biotechnology activist fund BVF has been pushing it to liquidate and return its cash to shareholders.

As illustrated in the chart above, if your vehicle is less than the amount of cash you have in the bank then buy liability insurance or minimum coverage.

They will be investigating how a company that was signed off by accountants, KPMG, as a solvent business in spring 2017 could crash into liquidation with a reported # 5bn of liabilities and just # 29m left in cash, less than a year later.